Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck and Small cell lung carcinoma to the study's listed conditions.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedHepatocellular Carcinoma was added to the conditions list, and the page revision was updated to v3.5.0.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page shows a routine version update from v3.4.2 to v3.4.3. No study content or data appears to have changed.SummaryDifference0.0%

- Check50 days agoChange DetectedGastric cancer has been added to the conditions section of the study page, including gastric/GEJ adenocarcinoma.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding status notice and Revision: v3.4.1.SummaryDifference0.3%

- Check64 days agoChange DetectedA new site-wide notice about government funding lapse and NIH Clinical Center status was added, and the site revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.